Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-10 11:03 am Purchase |
2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
The Vanguard Group | 5,131,197 7.980% |
1,606,998 (+45.60%) |
Filing History |
| 2021-02-05 06:10 am Sale |
2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
Sumitomo Mitsui Trust Group, Inc. | 5,104,362 7.940% |
-318,856 (-5.88%) |
Filing History |
| 2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | Intellia Therapeutics, Inc. NTLA |
BlackRock Inc. BLK |
5,052,845 8.600% |
1,407,615 (+38.62%) |
Filing History |
| 2021-01-22 4:59 pm Sale |
2021-01-21 | 13D | Intellia Therapeutics, Inc. NTLA |
Novartis Institutes for BioMedical Research Inc. | 2,176,148 3.700% |
-2,176,147 (-50.00%) |
Filing History |
| 2020-12-09 06:01 am Sale |
2020-11-30 | 13G | Intellia Therapeutics, Inc. NTLA |
Sumitomo Mitsui Trust Group, Inc. | 5,423,218 9.180% |
-1,755,302 (-24.45%) |
Filing History |
| 2020-12-08 4:26 pm Sale |
2020-11-30 | 13G | Intellia Therapeutics, Inc. NTLA |
Nikko Asset Management Americas, Inc. | 5,423,218 9.180% |
-1,755,302 (-24.45%) |
Filing History |
| 2020-08-20 4:30 pm Unchanged |
2020-08-06 | 13D | Intellia Therapeutics, Inc. NTLA |
Novartis Institutes for BioMedical Research Inc. | 4,352,295 7.400% |
0 (Unchanged) |
Filing History |